Our understanding of complex, ad-hoc pharmaceutical forecasting projects has stood the test of time. J+D methods are proven to have successfully supported clients for more than 10 years. We understand the challenges surrounding pharmaceutical forecasting. Our team of highly experienced people work alongside you, to drive forecasting processes and implement user friendly, yet intelligent models. Ultimately, the team must be confident in any recommendation they make for investment.
We separate our Bespoke forecasting models into 3 key areas:
Long Range Forecasting
Long range forecasting can be a challenging process due to global variation in data inputs, differences in reporting systems, indications in different countries, and role variation. We follow a 5 step process to ensure success and judge our success not simply on the technical rigour of the model, but the usability and engagement of all involved be that local affiliate or HQ.
Frequently, a mismatch between performance expectation and actual opportunity prevails and targets set can often be unrealistic. Often high performing accounts can be pressed for additional, unrealistic growth while under performing accounts continue to provide sub optimal numbers. J+D work alongside pharma brand teams to align growth expectations against the available opportunity and the level of investment required to achieve it.
The valuation of assets across the pipeline is a broad discipline that covers a wide range of forecasting needs. J+D NPP teams have a set of pharmaceutical forecasting models and templates in place that support best practice evaluations. We guide asset evaluations and forecasting process; encouraging risk and opportunity to be clearly defined, accessed and communicated in a consistent way.